<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Br J Clin Pharmacol</journal-id>
<journal-id journal-id-type="iso-abbrev">Br J Clin Pharmacol</journal-id>
<journal-id journal-id-type="doi">10.1111/(ISSN)1365-2125</journal-id>
<journal-id journal-id-type="publisher-id">BCP</journal-id>
<journal-title-group>
<journal-title>British Journal of Clinical Pharmacology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0306-5251</issn>
<issn pub-type="epub">1365-2125</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29863746</article-id>
<article-id pub-id-type="pmc">6138494</article-id>
<article-id pub-id-type="doi">10.1111/bcp.13656</article-id>
<article-id pub-id-type="publisher-id">BCP13656</article-id>
<article-id pub-id-type="other">RU-00029-18.R2</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Review</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Long‐term adverse effects of paracetamol – a review</article-title>
<alt-title alt-title-type="right-running-head">Long‐term adverse effects of paracetamol</alt-title>
<alt-title alt-title-type="left-running-head">J. C. McCrae et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" id="bcp13656-cr-0001">
<name>
<surname>McCrae</surname>
<given-names>J. C.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1009-0404</contrib-id>
<address>
<email>jcmccrae@gmail.com</email>
</address>
<xref ref-type="aff" rid="bcp13656-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bcp13656-cr-0002">
<name>
<surname>Morrison</surname>
<given-names>E. E.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4478-1550</contrib-id>
<xref ref-type="aff" rid="bcp13656-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bcp13656-cr-0003">
<name>
<surname>MacIntyre</surname>
<given-names>I. M.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4420-3822</contrib-id>
<xref ref-type="aff" rid="bcp13656-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bcp13656-cr-0004">
<name>
<surname>Dear</surname>
<given-names>J. W.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8630-8625</contrib-id>
<xref ref-type="aff" rid="bcp13656-aff-0001">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="bcp13656-cr-0005">
<name>
<surname>Webb</surname>
<given-names>D. J.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0755-1756</contrib-id>
<xref ref-type="aff" rid="bcp13656-aff-0001">
<sup>1</sup>
</xref>
</contrib>
</contrib-group>
<aff id="bcp13656-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">BHF Centre of Research Excellence (CoRE)</named-content>
<institution>Queen's Medical Research Institute, Pharmacology, Toxicology &amp; Therapeutics</institution>
<named-content content-type="city">Edinburgh</named-content>
<country country="GB">UK</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label>
Correspondence<break></break>
Dr Jame C McCrae, BHF Centre of Research Excellence (CoRE), Queen's Medical Research Institute, Pharmacology, Toxicology &amp; Therapeutics, Edinburgh, UK. E‐mail: <email>jcmccrae@gmail.com</email><break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>20</day>
<month>7</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>10</month>
<year>2018</year>
</pub-date>
<volume>84</volume>
<issue>10</issue>
<issue-id pub-id-type="doi">10.1111/bcp.v84.10</issue-id>
<fpage>2218</fpage>
<lpage>2230</lpage>
<history>
<date date-type="received">
<day>14</day>
<month>1</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>16</day>
<month>5</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>5</month>
<year>2018</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2018 The British Pharmacological Society <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2018 The British Pharmacological Society</copyright-statement>
</permissions>
<self-uri content-type="pdf" xlink:href="file:BCP-84-2218.pdf" xlink:type="simple"></self-uri>
<abstract>
<p>Paracetamol (acetaminophen) is the most commonly used drug in the world, with a long record of use in acute and chronic pain. In recent years, the benefits of paracetamol use in chronic conditions has been questioned, notably in the areas of osteoarthritis and lower back pain. Over the same period, concerns over the long‐term adverse effects of paracetamol use have increased, initially in the field of hypertension, but more recently in other areas as well. The evidence base for the adverse effects of chronic paracetamol use consists of many cohort and observational studies, with few randomized controlled trials, many of which contradict each other, so these studies must be interpreted with caution. Nevertheless, there are some areas where the evidence for harm is more robust, and if a clinician is starting paracetamol with the expectation of chronic use it might be advisable to discuss these side effects with patients beforehand. In particular, an increased risk of gastrointestinal bleeding and a small (~4 mmHg) increase in systolic blood pressure are adverse effects for which the evidence is particularly strong, and which show a degree of dose dependence. As our estimation of the benefits decreases, an accurate assessment of the harms is ever more important. The present review summarizes the current evidence on the harms associated with chronic paracetamol use, focusing on cardiovascular disease, asthma and renal injury, and the effects of <italic>in utero</italic> exposure.</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="bcp13656-kwd-0001">acetaminophen</kwd>
<kwd id="bcp13656-kwd-0002">adverse effects</kwd>
<kwd id="bcp13656-kwd-0003">asthma</kwd>
<kwd id="bcp13656-kwd-0005">gastrointestinal bleeding</kwd>
<kwd id="bcp13656-kwd-0006">hypertension</kwd>
<kwd id="bcp13656-kwd-0007">kidney disease</kwd>
</kwd-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="0"></table-count>
<page-count count="13"></page-count>
<word-count count="6683"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>bcp13656</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>October 2018</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.4.7.1 mode:remove_FC converted:14.09.2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="bcp13656-cit-0000" publication-type="journal">
<string-name>
<surname>McCrae</surname>, <given-names>J. C.</given-names>
</string-name>, <string-name>
<surname>Morrison</surname>, <given-names>E. E.</given-names>
</string-name>, <string-name>
<surname>MacIntyre</surname>, <given-names>I. M.</given-names>
</string-name>, <string-name>
<surname>Dear</surname>, <given-names>J. W.</given-names>
</string-name>, and <string-name>
<surname>Webb</surname>, <given-names>D. J.</given-names>
</string-name> (<year>2018</year>) <article-title>Long‐term adverse effects of paracetamol – a review</article-title>. <source xml:lang="en"/>Br J Clin Pharmacol, <volume>84</volume>: <fpage>2218</fpage>–<lpage>2230</lpage>. <pub-id pub-id-type="doi">10.1111/bcp.13656</pub-id>.</mixed-citation>
</p>
</notes>
</front>
</article>
</pmc-articleset>